PATENT CLAIM ANALYSIS

Application Number: 15994502
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2019-03
Patent Classification: ["514", "183000"]

Abstract:
The present invention describes methods and compositions for improving the therapeutic efficacy of therapeutic agents previously limited by suboptimal therapeutic performance by either improving efficacy as monotherapy or reducing side effects. Such methods and compositions are particularly applicable to bisantrene or derivatives, analogs, or prodrugs thereof.

Claim (Index 19):
The composition of  claim 12  wherein the composition comprises bisantrene and is formulated for use in a program of selecting appropriate additional indications for use wherein the indication for use is selected from the group consisting of:\n (a) use as an anti-infective agent; \n (b) use as an antiviral agent; \n (c) use as an antibacterial agent; \n (d) use for control of pleural effusions; \n (e) use as an antifungal agent; \n (f) use as an antiparasitic agent; \n (g) use for treatment of eczema; \n (h) use for treatment of shingles; \n (i) use for treatment of condylomata; \n (j) use for treatment of human papilloma virus (HPV); and \n (k) use for treatment of herpes simplex virus (HSV).

Metadata:
- Claim Count in Document: 2.0
- Percentile: 93.0
- Lexical Diversity: 1.31579
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15979041', '14907728', '14907729', '13817096', '14250958']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8177924956705994
- 35 USC 102 Novelty (BERT): 0.5309122609742489
- Combined Prediction Score: 0.7891044722009644
- Mean Citation Score: 276.52593
- Max Citation Score: 362.98706
- Similarity Product: 250.4882233566069

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test